Tg Therapeutics Inc (TGTX) returns
Tg Therapeutics returns over 10 years
$1,000 invested in Tg Therapeutics ten years ago was worth $10,809 at the close on October 30, 2026, with dividends reinvested: an average return of 26.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +9.7% | — | $1,097 | -0.9% |
| 3 months | +14.3% | — | $1,143 | +2.1% |
| Year to date | +105.2% | — | $2,052 | +11.7% |
| 1 year | +79.8% | — | $1,798 | +12.4% |
| 3 years | +727.9% | +102.3% | $8,279 | +88.5% |
| 5 years | +96.0% | +14.4% | $1,960 | +76.0% |
| 10 years | +980.9% | +26.9% | $10,809 | +316.6% |
Tg Therapeutics return by calendar year
| Year | TGTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +105.2% | +11.7% | +93.5% |
| 2025 | -1.0% | +17.7% | -18.7% |
| 2024 | +76.2% | +24.9% | +51.3% |
| 2023 | +44.4% | +26.2% | +18.2% |
| 2022 | -37.7% | -18.2% | -19.6% |
| 2021 | -63.5% | +28.7% | -92.2% |
| 2020 | +368.6% | +18.4% | +350.3% |
| 2019 | +170.7% | +31.2% | +139.5% |
| 2018 | -50.0% | -4.6% | -45.4% |
| 2017 | +76.3% | +21.7% | +54.6% |
| 2016 | -61.0% | +12.0% | -73.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TGTX financials · TGTX valuation
No forecast, no recommendation. This page describes Tg Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.